As patient communities and advocacy leaders become more deeply embedded in drug development, especially in rare diseases, it is imperative that organizations understand how patient engagement drives value beyond de-risking. Join Global Genes to hear insights on how patients are changing the landscape for the development of novel therapeutics and how researchers, drug developers and funders can better leverage patient-centric approaches to optimize value throughout development. Delve into how patient advocacy engagement and in drug development can act as a driver of investor value and learn how patient advocates are becoming market makers through their work in catalyzing scientific breakthroughs, data collection and sharing, reshaping clinical research, promoting access and building patient networks.

RSVP to gain access to this free virtual session

co-produced by: 

From De-risking to Value Creation – The Evolving Role of Patient Communities in Rare Disease Drug Development and Commercialization

Free On Demand Session 

All Rights Reserved. Forward ® 2020

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008

RARE Beyond the Square Partner Plus:

RARE Beyond the Square Partners: